Literature DB >> 21502600

Relationship of UV exposure to prevalence of multiple sclerosis in England.

S V Ramagopalan1, A E Handel, G Giovannoni, S Rutherford Siegel, G C Ebers, G Chaplin.   

Abstract

OBJECTIVE: To assess the potential relationship of ultraviolet B radiation (UVB) and Epstein-Barr virus (EBV) exposure in explaining the period prevalence of multiple sclerosis (MS) in England.
METHODS: English national Hospital Episode Statistics covering all admissions to National Health Service hospitals in England in the 7 years from 1998 to 2005 were used to obtain the period prevalences of MS and infectious mononucleosis (IM) in England. The United States National Aeronautics and Space Administration's data on UVB intensity for England from the Nimbus 7 satellite was collected. The relationships among the 3 variables (MS prevalence, IM prevalence, and UVB intensity) were investigated.
RESULTS: The regression of MS against UVB intensity for all seasons had an r(2) of 0.61; when including the interaction of IM with seasonal UVB, the r(2) rose to 0.72.
CONCLUSIONS: UVB exposure and IM together can explain a substantial proportion of the variance of MS. The effect of UVB on generating vitamin D seems the most likely candidate for explaining its relationship with MS. There is a pressing need to investigate the role of vitamin D and EBV and how they might interact to influence MS risk to identify potential prevention strategies.

Entities:  

Mesh:

Year:  2011        PMID: 21502600      PMCID: PMC3087404          DOI: 10.1212/WNL.0b013e318216715e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

Review 1.  The worldwide prevalence of multiple sclerosis.

Authors:  Maura Pugliatti; Stefano Sotgiu; Giulio Rosati
Journal:  Clin Neurol Neurosurg       Date:  2002-07       Impact factor: 1.876

2.  MS prevalence in New Zealand, an ethnically and latitudinally diverse country.

Authors:  Bruce V Taylor; John F Pearson; Glynnis Clarke; Deborah F Mason; David A Abernethy; Ernie Willoughby; Clive Sabel
Journal:  Mult Scler       Date:  2010-09-02       Impact factor: 6.312

Review 3.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 4.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors.

Authors:  Alberto Ascherio; Kassandra L Munger
Journal:  Ann Neurol       Date:  2007-06       Impact factor: 10.422

Review 5.  Environmental factors and multiple sclerosis.

Authors:  George C Ebers
Journal:  Lancet Neurol       Date:  2008-03       Impact factor: 44.182

Review 6.  Biology and disease associations of Epstein-Barr virus.

Authors:  D H Crawford
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

7.  Timing of birth and risk of multiple sclerosis: population based study.

Authors:  Cristen J Willer; David A Dyment; A Dessa Sadovnick; Peter M Rothwell; T Jock Murray; George C Ebers
Journal:  BMJ       Date:  2004-12-07

8.  An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.

Authors:  Adam E Handel; Alexander J Williamson; Giulio Disanto; Lahiru Handunnetthi; Gavin Giovannoni; Sreeram V Ramagopalan
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

9.  A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution.

Authors:  Sreeram V Ramagopalan; Andreas Heger; Antonio J Berlanga; Narelle J Maugeri; Matthew R Lincoln; Amy Burrell; Lahiru Handunnetthi; Adam E Handel; Giulio Disanto; Sarah-Michelle Orton; Corey T Watson; Julia M Morahan; Gavin Giovannoni; Chris P Ponting; George C Ebers; Julian C Knight
Journal:  Genome Res       Date:  2010-08-24       Impact factor: 9.043

10.  Geography of hospital admissions for multiple sclerosis in England and comparison with the geography of hospital admissions for infectious mononucleosis: a descriptive study.

Authors:  Sreeram V Ramagopalan; Uy Hoang; Valerie Seagroatt; Adam Handel; George C Ebers; Gavin Giovannoni; Michael J Goldacre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-01-06       Impact factor: 10.154

View more
  30 in total

1.  Multiple sclerosis: is prevalence rising and if so why?

Authors:  Julián Benito-León
Journal:  Neuroepidemiology       Date:  2011-11-30       Impact factor: 3.282

2.  Catalpol induces oligodendrocyte precursor cell-mediated remyelination in vitro.

Authors:  Chun-Xiao Yuan; Takho Chu; Li Liu; Hao-Wen Li; Ya-Jie Wang; An-Chen Guo; Yong-Ping Fan
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

3.  Latitude has more significant impact on prevalence of multiple sclerosis than ultraviolet level or sunshine duration in Japanese population.

Authors:  Masako Kinoshita; Kaoru Obata; Masami Tanaka
Journal:  Neurol Sci       Date:  2015-03-10       Impact factor: 3.307

4.  Human skin pigmentation, migration and disease susceptibility.

Authors:  Nina G Jablonski; George Chaplin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

5.  Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor.

Authors:  Yanping Wang; Steven J Marling; Jinge G Zhu; Kyle S Severson; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-16       Impact factor: 11.205

6.  Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.

Authors:  Margitta T Kampman; Jan Harald Aarseth; Nina Grytten; Espen Benjaminsen; Elisabeth Gulowsen Celius; Ole Petter Dahl; Trygve Holmøy; Kristin Løken-Amsrud; Rune Midgard; Kjell-Morten Myhr; Geir Risberg; Anita Vatne; Oivind Torkildsen
Journal:  J Neurol       Date:  2013-01-06       Impact factor: 4.849

7.  Circulating microRNAs involved in multiple sclerosis.

Authors:  Sue Rutherford Siegel; Jason Mackenzie; George Chaplin; Nina G Jablonski; Lyn Griffiths
Journal:  Mol Biol Rep       Date:  2012-01-10       Impact factor: 2.316

8.  Contribution of GPR30 for 1,25 dihydroxyvitamin D₃ protection in EAE.

Authors:  Sandhya Subramanian; Lisa M Miller; Marjorie R Grafe; Arthur A Vandenbark; Halina Offner
Journal:  Metab Brain Dis       Date:  2011-10-13       Impact factor: 3.584

Review 9.  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Authors:  Celia Oreja-Guevara; Heinz Wiendl; Bernd C Kieseier; Laura Airas
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

10.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.